BCBSA joins Civica, Rx and hospitals to make their own generic medications

Civica, Rx, a non-profit venture works with generic drug companies to manufacture medications that are in short supply or subject to price spikes, is now supplying 18 generic drugs along with their first medicine, the antibiotic Vancomycin, to nearly 50 health systems, representing more than 1,200 member hospitals. With the recent announcement by the Blue Cross Blue Shield Association, along with 18 independent Blue Cross and Blue Shield insurers, they are investing $55 million into Civica to form a subsidiary aimed at lowering the price of costly generic drugs.  The new subsidiary will focus on manufacturing seven to 10 high-price medications, with the first ones available by early 2022. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.